{"id":6214,"date":"2013-04-15T18:05:00","date_gmt":"2013-04-15T18:05:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/fdas-abrams-repeats-same-old-promise-re\/"},"modified":"2019-02-21T01:17:31","modified_gmt":"2019-02-21T01:17:31","slug":"fdas-abrams-repeats-same-old-promise-re","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/","title":{"rendered":"FDA’s Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance"},"content":{"rendered":"

According to a Pharmalot headline, FDA’s Tom Abrams — who heads the Office of Prescription Drug Promotion — promises that “Long-Awaited Social Media Guidance Is Coming” (see here<\/a>).<\/p>\n

Despite Ed Silverman’s valiant attempts to pin Abrams down to a specific time frame, all he was able to get from Abrams was “It\u2019s hard to anticipate the time, because there are many steps involved.”<\/p>\n

Abrams wouldn’t even commit to the July 9, 2014, deadline mandated by Section 1121 in FDASIA. “Our intention is to make that,” said Abrams. “Any chance you can make it sooner?,” asked Silverman. “We are striving to make it as soon as possible,” said Abrams.<\/p>\n

Abrams emphasized the “many steps” involved in the process and that his peeps “are working very, very thoroughly and very hard \u2013 people are putting in extra hours.”<\/p>\n

So what progress has FDA made? What actions have been completed? Surely, after all the extra hours there must be some progress to report.<\/p>\n

According the FDASIA-TRACK<\/a> site, through which FDA “will communicate its progress towards accomplishing the requirements of the FDA Safety and Innovation Act,” the agency has completed NO actions with regard to “issuing guidance describing FDA policy regarding Internet promotion, including social media, of medical products regulated by FDA.” Here’s the section of the FDASIA-TRACK showing the lack of progress as of March 29, 2013:<\/p>\n

\n<\/a><\/div>\n

\nI stand by my prediction that the FDA will prevaricate and delay the issuance of social media guidance until it reaches the very edge of the July, 2014, “Social Media Guidance Cliff” and Beyond! For more on that, see here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

According to a Pharmalot headline, FDA’s Tom Abrams — who heads the Office of Prescription Drug Promotion — promises that “Long-Awaited Social Media Guidance Is Coming” (see here). Despite Ed Silverman’s valiant attempts to pin Abrams down to a specific time frame, all he was able to get from Abrams was “It\u2019s hard to anticipate […]<\/p>\n","protected":false},"author":2,"featured_media":11155,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[304,145,167],"topic":[],"acf":[],"yoast_head":"\nFDA's Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA's Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"According to a Pharmalot headline, FDA’s Tom Abrams — who heads the Office of Prescription Drug Promotion — promises that “Long-Awaited Social Media Guidance Is Coming” (see here). Despite Ed Silverman’s valiant attempts to pin Abrams down to a specific time frame, all he was able to get from Abrams was “It\u2019s hard to anticipate […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2013-04-15T18:05:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-21T01:17:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2013\/04\/FDASIA-TRACK-SMentry.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"126\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/\",\"url\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/\",\"name\":\"FDA's Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2013-04-15T18:05:00+00:00\",\"dateModified\":\"2019-02-21T01:17:31+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA’s Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA's Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/","og_locale":"en_US","og_type":"article","og_title":"FDA's Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance - Pharma Marketing Network","og_description":"According to a Pharmalot headline, FDA’s Tom Abrams — who heads the Office of Prescription Drug Promotion — promises that “Long-Awaited Social Media Guidance Is Coming” (see here). Despite Ed Silverman’s valiant attempts to pin Abrams down to a specific time frame, all he was able to get from Abrams was “It\u2019s hard to anticipate […]","og_url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/","og_site_name":"Pharma Marketing Network","article_published_time":"2013-04-15T18:05:00+00:00","article_modified_time":"2019-02-21T01:17:31+00:00","og_image":[{"width":640,"height":126,"url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2013\/04\/FDASIA-TRACK-SMentry.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/","url":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/","name":"FDA's Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2013-04-15T18:05:00+00:00","dateModified":"2019-02-21T01:17:31+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fdas-abrams-repeats-same-old-promise-re\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"FDA’s Abrams Repeats Same Old (Empty) Promises Regarding the Issuing of Social Media Guidance"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6214"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=6214"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6214\/revisions"}],"predecessor-version":[{"id":11156,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6214\/revisions\/11156"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/11155"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=6214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=6214"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=6214"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=6214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}